Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.807 | 0.160 | 10 | 111079821 | 3 prime UTR variant | A/G;T | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.050 | 1.000 | 5 | 2011 | 2018 | ||||||||
|
0.790 | 0.160 | 10 | 111076745 | upstream gene variant | G/C | snv | 0.59 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2010 | 2014 | |||||||
|
0.790 | 0.160 | 10 | 111076745 | upstream gene variant | G/C | snv | 0.59 |
|
Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.020 | 1.000 | 2 | 2015 | 2018 | |||||||
|
0.925 | 0.080 | 10 | 111078794 | missense variant | C/G;T | snv | 1.9E-03 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2006 | 2006 | |||||||
|
0.925 | 0.080 | 10 | 111078794 | missense variant | C/G;T | snv | 1.9E-03 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | < 0.001 | 1 | 2006 | 2006 | |||||||
|
0.925 | 0.080 | 10 | 111078794 | missense variant | C/G;T | snv | 1.9E-03 |
|
Behavior and Behavior Mechanisms | 0.010 | < 0.001 | 1 | 2006 | 2006 | |||||||
|
0.925 | 0.080 | 10 | 111078794 | missense variant | C/G;T | snv | 1.9E-03 |
|
Behavior and Behavior Mechanisms | 0.010 | < 0.001 | 1 | 2006 | 2006 | |||||||
|
10 | 111079134 | synonymous variant | C/A | snv | 7.4E-02 | 4.9E-02 |
|
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.790 | 0.160 | 10 | 111076745 | upstream gene variant | G/C | snv | 0.59 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.160 | 10 | 111076745 | upstream gene variant | G/C | snv | 0.59 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.790 | 0.160 | 10 | 111076745 | upstream gene variant | G/C | snv | 0.59 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.790 | 0.160 | 10 | 111076745 | upstream gene variant | G/C | snv | 0.59 |
|
Wounds and Injuries | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.790 | 0.160 | 10 | 111076745 | upstream gene variant | G/C | snv | 0.59 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.790 | 0.160 | 10 | 111076745 | upstream gene variant | G/C | snv | 0.59 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.790 | 0.160 | 10 | 111076745 | upstream gene variant | G/C | snv | 0.59 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.790 | 0.160 | 10 | 111076745 | upstream gene variant | G/C | snv | 0.59 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.790 | 0.160 | 10 | 111076745 | upstream gene variant | G/C | snv | 0.59 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.160 | 10 | 111076745 | upstream gene variant | G/C | snv | 0.59 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
10 | 111079843 | 3 prime UTR variant | C/A | snv | 8.7E-02 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
10 | 111079843 | 3 prime UTR variant | C/A | snv | 8.7E-02 |
|
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
0.925 | 0.160 | 10 | 111075832 | upstream gene variant | T/A | snv | 0.57 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.160 | 10 | 111075832 | upstream gene variant | T/A | snv | 0.57 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.160 | 10 | 111079821 | 3 prime UTR variant | A/G;T | snv |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.807 | 0.160 | 10 | 111079821 | 3 prime UTR variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.807 | 0.160 | 10 | 111079821 | 3 prime UTR variant | A/G;T | snv |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |